---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-25-000024"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:45:49.351128+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific CFO Dan Brennan to retire; Jon Monson named successor effective June 30, 2025

## Summary
- Dan Brennan retires as EVP & CFO effective June 29, 2025; will remain senior advisor to October 3, 2025.
- Jon Monson promoted to EVP & CFO effective June 30, 2025; previously SVP, Investor Relations and global controller.
- Monson receives base salary of $700,000, bonus target of 80%, and $1.75M equity award vesting over 4 years.
- Monson has been with Boston Scientific for 25+ years; played key roles in finance during pandemic and strategic investments.

## SEC filing metadata
- accession: 0000885725-25-000024
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/bsx-20250418.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-25-000024
- JSON: https://secwatch.observer/filing/0000885725-25-000024.json
- Plain text: https://secwatch.observer/filing/0000885725-25-000024.txt

## Key facts
- Executive change
  Jonathan Monson was appointed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.
  - Action: promoted
  - Role: Executive Vice President and Chief Financial Officer
  source text: Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm
- Executive change
  Daniel J. Brennan departed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.
  - Action: retire
  - Role: Executive Vice President and Chief Financial Officer
  source text: On April 23, 2025, Boston Scientific Corporation (the “Company”) announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.